Evaluation of NT-proBNP in conjunction with other predictors of unsuccessful cardioversion or AF recurrence (such as age, weight, AF duration, persistent AF, previous AF recurrence, heart failure, and LA diameter) [65,66,67], may serve as a valuable non-invasive tool that would assist clinicians in the ED to tailor appropriate treatment. The gene discussed is NPPB; the disease is atrial fibrillation.